Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Wood, K. Fudge, J. Mohler, Andra Frost, F. Garcia, Min Wang, M. Stearns (1997)
In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancerClinical & Experimental Metastasis, 15
L. Shao, Huanjie Li, Jian Chen, Haibo Song, Yuzhu Zhang, Fei Wu, Wenjuan Wang, Wen Zhang, Fang Wang, Hui Li, D. Tang (2017)
Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition.Biochemical and biophysical research communications, 485 3
S. Aydin, T. Kuloğlu, S. Aydin, M. Eren, A. Çelik, M. Yılmaz, M. Kalaycı, I. Sahin, Orhan Gungor, A. Gurel, M. Ogeturk, Ozlem Dabak (2014)
Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: Cardiac muscle produces more irisin than skeletal musclePeptides, 52
M. Toi, S. Ishigaki, T. Tominaga (2004)
Metalloproteinases and tissue inhibitors of metalloproteinasesBreast Cancer Research and Treatment, 52
(Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F. Microbiota and prostate cancer. Semin Cancer Biol. 2021. 10.1016/j.semcancer.2021.09.007..)
Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F. Microbiota and prostate cancer. Semin Cancer Biol. 2021. 10.1016/j.semcancer.2021.09.007..Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F. Microbiota and prostate cancer. Semin Cancer Biol. 2021. 10.1016/j.semcancer.2021.09.007.., Rizzo A, Santoni M, Mollica V, Fiorentino M, Brandi G, Massari F. Microbiota and prostate cancer. Semin Cancer Biol. 2021. 10.1016/j.semcancer.2021.09.007..
Soo Lee, Xiaodong Yang, Shan-zhou Duan, Y. Tsai, Laura Strojny, P. Keng, Yuhchyau Chen (2015)
IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancerOncotarget, 7
M. Gomarasca, G. Banfi, G. Lombardi (2020)
Myokines: The endocrine coupling of skeletal muscle and bone.Advances in clinical chemistry, 94
L. Simi, M. Andreani, F. Davini, A. Janni, M. Pazzagli, M. Serio, C. Orlando (2004)
Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR.Lung cancer, 45 2
P. Henriet, L. Blavier, Y. DeClerck (1999)
Tissue inhibitors of metalloproteinases (TEMP) in invasion and proliferationAPMIS, 107
J. Quan, Gengyuan Cai, Jian Ye, Ming Yang, R. Ding, Xingwang Wang, E. Zheng, Disheng Fu, Shaoyun Li, Shenping Zhou, Dewu Liu, Jie Yang, Zhenfang Wu (2018)
A global comparison of the microbiome compositions of three gut locations in commercial pigs with extreme feed conversion ratiosScientific Reports, 8
M. Stearns, Stearns Me (1996)
Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression.Oncology research, 8 2
Stefanie Löffek, O. Schilling, Franzke Cw (2010)
Biological role of matrix metalloproteinases: a critical balanceEuropean Respiratory Journal, 38
Dewan Sumsuzzman, Yunho Jin, Jeonghyun Choi, Jeong-Hee Yu, T. Lee, Yonggeun Hong (2019)
Pathophysiological role of endogenous irisin against tumorigenesis and metastasis: Is it a potential biomarker and therapeutic?Tumor Biology, 41
Jun Wu, P. Boström, L. Sparks, L. Ye, J. Choi, An-Hoa Giang, M. Khandekar, K. Virtanen, P. Nuutila, G. Schaart, Kexin Huang, H. Tu, W. Lichtenbelt, J. Hoeks, S. Enerbäck, P. Schrauwen, B. Spiegelman (2012)
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and HumanCell, 150
M. Egeblad, Z. Werb (2002)
New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2
M. Kodate, T. Kasai, Hiroshi Hashirnoto, K. Yasumoto, Y. Iwata, H. Manabe (1997)
Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lungPathology International, 47
B. Lokeshwar (1999)
MMP Inhibition in Prostate CancerAnnals of the New York Academy of Sciences, 878
Jiayu Liu, N. Song, Yibing Huang, Yuxin Chen (2018)
Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathwayScientific Reports, 8
Guangjun Shi, N. Tang, J. Qiu, Deguo Zhang, F. Huang, Ya-Yuan Cheng, Kun Ding, Weisheng Li, Ping Zhang, Xueying Tan (2017)
Irisin stimulates cell proliferation and invasion by targeting the PI3K/AKT pathway in human hepatocellular carcinoma.Biochemical and biophysical research communications, 493 1
R. Qureshi, H. Arora, M. Rizvi (2015)
EMT in cervical cancer: its role in tumour progression and response to therapy.Cancer letters, 356 2 Pt B
(2016)
Irisin immunostaining characteristics of breast and ovarian cancer cellsCell Mol Biol (Noisy-le-grand), 62
Jin Meng, Xu-tao Zhang, Xinli Liu, Lei Fan, Chen Li, Yang Sun, Xiao-hua Liang, Jian-bo Wang, Q. Mei, Feng Zhang, Tao Zhang (2016)
WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.Cellular signalling, 28 11
T. Kuloğlu, O. Celik, S. Aydin, I. Ozercan, M. Acet, Y. Aydin, G. Artas, A. Turk, M. Yardim, G. Ozan, M. Yalcin, N. Kocaman (2016)
Molecular talk of adipokines in dermatological diseases.Cellular and Molecular Biology, 62
Songul Aktas (2018)
Multigravidas' perceptions of traumatic childbirth: Its relation to some factors, the effect of previous type of birth and experienceMedicine Science | International Medical Journal, 7
B. Nawrocki, M. Polette, V. Marchand, M. Monteau, P. Gillery, J. Tournier, P. Birembaut (1997)
Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: Quantificative and morphological analysesInternational Journal of Cancer, 72
T. Kuloğlu, S. Aydin, M. Eren, M. Yılmaz, I. Sahin, M. Kalaycı, E. Sarman, N. Kaya, O. Yilmaz, A. Turk, Y. Aydin, M. Yalçın, Nimet Uras, A. Gurel, S. Ilhan, E. Gul, S. Aydin (2014)
Irisin: A potentially candidate marker for myocardial infarctionPeptides, 55
S. Aydin, T. Kuloğlu, M. Ozercan, S. Albayrak, S. Aydin, U. Bakal, M. Yilmaz, M. Kalaycı, M. Yardim, M. Saraç, A. Kazez, H. Koçdor, B. Kanat, İH Ozercan, M. Gonen, M. Bilgen, F. Balgetir (2016)
Irisin immunohistochemistry in gastrointestinal system cancersBiotechnic & Histochemistry, 91
R. Lichtinghagen, P. Musholt, M. Lein, A. Roemer, B. Rudolph, G. Kristiansen, S. Hauptmann, D. Schnorr, S. Loening, K. Jung (2002)
Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue.European urology, 42 4
A. Rizzo, V. Mollica, M. Rosellini, Andrea Marchetti, A. Ricci, M. Fiorentino, N. Battelli, M. Santoni, F. Massari (2021)
Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials.Pathology, research and practice, 222
J. Moreno-Navarrete, F. Ortega, Marta Serrano, E. Guerra, Gerard Pardo, F. Tinahones, W. Ricart, J. Fernández-Real (2013)
Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.The Journal of clinical endocrinology and metabolism, 98 4
F. Hamdy, EJ Fadlon, D. Cottam, J. Lawry, W. Thurrell, PB Silcocks, Jb Anderson, Jl Williams, R. Rees (1994)
Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia.British Journal of Cancer, 69
K. Edmunds, H. Tuffaha, P. Scuffham, D. Galvão, R. Newton (2020)
The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid reviewSupportive Care in Cancer, 28
A. Strongin, I. Collier, G. Bannikov, B. Marmer, G. Grant, G. Goldberg (1995)
Mechanism Of Cell Surface Activation Of 72-kDa Type IV CollagenaseThe Journal of Biological Chemistry, 270
(1986)
Inducibility of j immunoglobulin enhancer-binding protein NF-jB by a posttranslational mechanism
M. Raeeszadeh-Sarmazdeh, L. Do, Brianne Hritz (2020)
Metalloproteinases and Their Inhibitors: Potential for the Development of New TherapeuticsCells, 9
M. Polette, B. Nawrocki-Raby, C. Gilles, C. Clavel, P. Birembaut (2004)
Tumour invasion and matrix metalloproteinases.Critical reviews in oncology/hematology, 49 3
W. Zhong, Zhao‐dong Han, H. He, X. Bi, Q. Dai, Gang Zhu, Yong-kang Ye, Yu-Xiang Liang, Wei-jun Qin, Z. Zhang, Guo-hua Zeng, Zhi-Nan Chen (2008)
CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate CancerOncology, 75
(1997)
Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analysesInt J Cancer., 72
P. Boström, Jun Wu, Mark Jedrychowski, Anisha Korde, L. Ye, J. Lo, K. Rasbach, E. Boström, J. Choi, J. Long, S. Kajimura, M. Zingaretti, B. Vind, H. Tu, S. Cinti, K. Højlund, S. Gygi, B. Spiegelman (2012)
A PGC1α-dependent myokine that drives browning of white fat and thermogenesisNature, 481
Hye Lee, J. Lee, Nami Kim, Joong Kim, Hyung Kim, Yong Lee, S. Kim, Jong-Il Choi, Y. Oh, Jeong Kim, Suyeon Hwang, S. Park, Hyeon Kim (2015)
Irisin, a Novel Myokine, Regulates Glucose Uptake in Skeletal Muscle Cells via AMPK.Molecular endocrinology, 29 6
G. Kong, Yunpeng Jiang, Xiujiang Sun, Z. Cao, Guodong Zhang, Zhongyuan Zhao, Yong Zhao, Q. Yu, G. Cheng (2017)
Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathwayOncology Reports, 38
S. Reis, A. Antunes, José Pontes‐Júnior, Juliana Sousa-Canavez, M. Dall'oglio, C. Piantino, J. Cruz, D. Morais, M. Srougi, K. Leite (2012)
Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.International braz j urol : official journal of the Brazilian Society of Urology, 38 2
C. Gialeli, A. Theocharis, Nikos Karamanos (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targetingThe FEBS Journal, 278
X. Provatopoulou, G. Georgiou, E. Kalogera, V. Kalles, M. Matiatou, I. Papapanagiotou, A. Sagkriotis, G. Zografos, A. Gounaris (2015)
Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristicsBMC Cancer, 15
(2011)
Evaluation of prostate cancer prevalence in Iranian male population with increased PSA level, a one center experienceCancer Manag Res, 3
A. Rizzo, M. Santoni, V. Mollica, M. Fiorentino, G. Brandi, F. Massari (2021)
Microbiota and prostate cancer.Seminars in cancer biology
R. Ahima, H. Park (2015)
Connecting Myokines and MetabolismEndocrinology and Metabolism, 30
H. Miyamoto, E. Messing, Chawnshang Chang (2004)
Androgen deprivation therapy for prostate cancer: Current status and future prospectsThe Prostate, 61
J. Huh, G. Panagiotou, V. Mougios, Mary Brinkoetter, Maria Vamvini, B. Schneider, C. Mantzoros (2012)
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.Metabolism: clinical and experimental, 61 12
H. Foda, S. Zucker (2001)
Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis.Drug discovery today, 6 9
G. Pourmand, S. Salem, A. Mehrsai, M. Lotfi, M. Amirzargar, H. Mazdak, A. Roshani, Abdolreza Kheirollahi, E. Kalantar, N. Baradaran, B. Saboury, F. Allameh, A. Karami, H. Ahmadi, Y. Jahani (2007)
The risk factors of prostate cancer: a multicentric case-control study in Iran.Asian Pacific journal of cancer prevention : APJCP, 8 3
M. Ruth (2012)
A PGC1–α–dependent myokine that drives brown–fat–like development of white fat and thermogenesisYearbook of Endocrinology, 2012
N. Liabakk, I. Talbot, Rosealee Smith, K. Wilkinson, F. Balkwill (1996)
Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer.Cancer research, 56 1
(2016)
Interleukin-32a inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cells
P. Hoffman, B. Djavan (2008)
Androgen deprivation therapy.Reviews in urology, 10 4
C. Scheau, I. Badarau, R. Costache, C. Caruntu, Gratiela Mihai, A. Didilescu, C. Constantin, M. Neagu (2019)
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular CarcinomaAnalytical Cellular Pathology (Amsterdam), 2019
Mohammad Moslemi, Fariborz Lotfi, Ali Tahvildar
Cancer Management and Research Dovepress Evaluation of Prostate Cancer Prevalence in Iranian Male Population with Increased Psa Level, a One Center Experience
J. Nedergaard, T. Bengtsson, B. Cannon (2007)
Unexpected evidence for active brown adipose tissue in adult humans.American journal of physiology. Endocrinology and metabolism, 293 2
S. Curran, G. Murray (2000)
Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.European journal of cancer, 36 13 Spec No
L. Bourke, S. Boorjian, A. Briganti, L. Klotz, L. Mucci, M. Resnick, D. Rosario, T. Skolarus, D. Penson (2015)
Survivorship and improving quality of life in men with prostate cancer.European urology, 68 3
Fei Wu, Haibo Song, Yuan Zhang, Yuzhu Zhang, Qian Mu, Miao Jiang, F. Wang, Wen Zhang, Liang Li, Huanjie Li, Yunshan Wang, Ming-Xiang Zhang, Shiwu Li, Lijun Yang, Y. Meng, D. Tang, K. Arai (2015)
Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling PathwayPLoS ONE, 10
Guang-xu Zhu, Jin-xiang Wang, Ming-bao Song, Fang Zhou, Dagan Fu, Guang-ping Ruan, Xiang-qing Zhu, Yinyin Bai, Lan Huang, R. Pang, Hua-li Kang, Xinghua Pan (2016)
Irisin Increased the Number and Improved the Function of Endothelial Progenitor Cells in Diabetes Mellitus MiceJournal of Cardiovascular Pharmacology, 68
IntroductionIrisin is a newly discovered myokine released from skeletal muscle during exercise. The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that play a key role in the metastatic process via degrading extracellular matrix. The aim of this study was to investigate the effect of irisin on expression of metastatic markers MMP2 and MMP9 and induced apoptosis in human prostate cancer cells.MethodsIn this study, we examined the effect of different concentrations of irisin on induced apoptosis and cell viability of two cell lines, LNCaP and DU-145, by using flow cytometry and MTT assay, respectively. The expression of MMP2 and MMP9 genes was also analyzed by real-time PCR after irisin treatment. Data were analyzed using the comparative cycle threshold 2−∆∆Ct method.ResultsCell viability was reduced in both LNCaP and DU-145 cell lines at different concentrations of irisin. However, this decreased cell viability was strongly significant (p < 0.05) only at 5 and 10 nM concentrations of irisin in the LNCaP cell line. Furthermore, irisin could induce apoptosis in both cell lines at a concentration of 10 nM compared to 5 nM. Real-time PCR results also demonstrated a decreased expression in MMP2 and MMP9 genes in a concentration-dependent manner in both cell lines.ConclusionThese results showed the anticancer effects of irisin on cell viability of both LNCaP and DU-145 cell lines and also on the expression of MMP2 and MMP9 genes occurred in a dose- and time-dependent manner.
Oncology and Therapy – Springer Journals
Published: Dec 1, 2022
Keywords: Prostate cancer; Irisin; Matrix metalloproteinase; Metastasis; Cell line
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.